DevelopAKUre is a
series of major international clinical trials, run by a consortium of 12
European partners. It aims to study a potential new drug, called
nitisinone, and assess its potential effectiveness in treating the rare
disease, alkaptonuria (AKU).
DevelopAKUre is co-funded by a grant from the European
Commission. This website is run by a UK patient group, the AKU Society. Learn more about AKU on the AKU Society's What is AKU page.